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Abstract
Background/Aims: Myocardial reperfusion has the potential to salvage the ischemic
myocardium after a period of coronary occlusion. Reperfusion, however, can cause a wide
spectrum of deleterious effects. Galectin-3 (GAL-3), a beta galactoside binding lectin, is closely
associated with myocardial infarction (MI), myocardial fibrosis and heart failure. In our study,
we investigated its role in ischemia-reperfusion injuries (IR) as this phenomenon is extremely
relevant to the early intervention after acute MI. Methods: C57B6/J wild type (WT) mice and
GAL-3 knockout (KO) mice were used for murine model of IR injury in the heart where a
period of 30 minutes ischemia was followed by 24 hours of reperfusion. Heart samples were
processed for immunohistochemical and immunofluorescent labeling, morphometric analysis,
western blot and enzyme-linked immunosorbent assay to identify the apoptotic, inflammatory
and oxidative stress role of GAL-3. Results: Our results show that there was a significant
increase in GAL-3 levels in the heart which shows GAL-3 is playing a role in the ischemia
reperfusion injury. Troponin I was also significantly higher in GAL-3-KO group than wild type.
Our study shows that GAL-3 is associated with an increase in the antioxidant activity in the
IR injured myocardium. Antioxidant enzymes superoxide dismutase, glutathione and catalase
were found to be significantly raised in the GAL-3 wild type IR as compared to the GAL-3 KO IR
group. A significant increase in apoptotic activity is seen in GAL-3 KO IR group as compared
with GAL-3 wild IR group. Conclusion: Our study shows that GAL-3 can affect the redox
pathways, controlling cell survival and death, and plays a protective role on the myocardium
following IR injury.
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Introduction

Early and successful myocardial reperfusion after an acute myocardial infarction (MI) is
the most effective strategy for salvaging the myocardium and improving clinical outcomes.
This process of restoring blood flow to the ischemic myocardium can, however, induce
myocardial reperfusion injury and paradoxically reduce the beneficial effects of myocardial
reperfusion. This injury results in the death of cardiac myocytes that were viable immediately
before myocardial reperfusion [1], hence, despite prompt myocardial reperfusion, the rate of
death after an acute MI approaches 9%, and the incidence of cardiac failure is almost 10%
at 1 year [2, 3].
The concept of ischemia reperfusion (IR) injury was first introduced when scientists
noticed that a large fraction of cellular enzymes were released not during hypoxia, but on
sudden re-oxygenation [4]. This re-oxygenation of ischemic myocardium generates a degree
of myocardial injury that exceeds injury induced by ischemia alone [4]. Timely reperfusion
after MI can reduce the size of infarction up-to half, which means that reperfusion itself
accounts for up-to 50% of final infarct size [5]. Reperfusion is also shown to affect a larger
portion of the left ventricle than infarction alone, so IR injury may act as an independent
determinant of cardiac remodeling [6].
IR injury is a combination of events that begins with oxidative stress, inflammation,
intracellular Ca+ overload and subsequent progression into irreversible cell death by
apoptosis and necrosis [7, 8]. Understanding the contribution of these processes to IR injury
is essential to look for therapeutic measures that can help reduce the myocardial infarct size
and cardiac remodeling; both crucial determinants of prognosis.
Galectin-3 (GAL-3) is unique chimera-like galectin belonging to the family of lectins that
specifically bind to N-acetyl-lactosamine-containing glycoproteins [9]. GAL-3 is expressed in
a variety of cells, e.g., endothelial and epithelial cells, activated macrophages, microglial cells,
basophils, mast cells, neutrophils, neurons and cardiomyocytes [10-16]. So far we know that
GAL-3 is closely associated with myocardial infarction in the early post MI period and later
with myocardial fibrosis and heart failure [15, 17]. Our aim is to further investigate if GAL-3
has any role in IR injury of the myocardium.
The generation of reactive oxygen species (ROS) acts as central mediators of IR
injury. These species can initiate spontaneous, and self-propagating radical reactions with
biomolecules that impair myocardial function by activating intracellular proteolytic enzymes
and induce cell death by initiating mitochondrial permeability transition [18, 19]. Most cells
including cardiomyocytes contain enzymatic antioxidant defense mechanisms that quickly
convert ROS to water. These antioxidant systems include superoxide dismutase, catalase, and
the glutathione (GSH) redox system [20]. In addition to looking at the antioxidant enzyme
activity in relation to GAL-3, we will look into the role of NRF2 (Nuclear factor-erythroid 2
(NF-E2)-related factor 2) which is a redox-sensitive transcription factor that up-regulates
cytoprotective and antioxidant genes expression to protect against IR injury. During
resting state, NRF2 is located in the cytoplasm sequestered with a cytoskeletal associated
protein Keap 1 (Kelch-like ECH-associated protein 1). Keap 1 negatively regulates NRF2 by
promoting its ubiquitination and proteosomal degradation. When released from Keap 1,
NRF2 translocate to the nucleus and binds as a heterodimer to the antioxidant response
elements (ARE) located in the promoter region of genes encoding many antioxidant enzymes
[21-24]. NRF2 thus controls GSH production and regeneration and its utilization among
other antioxidant pathways [25]. Also in the myocardium, NRF2 is a critical element of redox
homeostasis [26, 27]. Recently it has been demonstrated that in addition to protection
against oxidative stresses NRF2 responds to pro-inflammatory stimuli and protects against
inflammatory injuries and fibrosis [28-30].
We hypothesize that GAL-3 has a protective role on the myocardium during IR injury.
We have used a murine model of myocardial ischemia-reperfusion injury with a period of 30
min ischemia followed by 24 hours of reperfusion to investigate the protective role of GAL-3
in IR injury through measuring myocardial inflammatory markers (IL-6, CRP, MPO, elastase),
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cell death markers (Troponin I, cleaved caspase-3, cytochrome c, annexin V), cell survival
marker (Bcl2) and anti-oxidant markers (GSH, catalase, SOD, NRF2, glutathione reductase,
glutathione peroxidase).
Materials and Methods
Murine model of myocardial ischemia reperfusion injury
C57B6/J wild type (WT) (n=16) and GAL-3 knockout (KO) (The Jackson Laboratory, 006338, galactin3-,
B6 Cg-Lgals3 <tm 1 Poi>/J HOM Homozygous genotype) (n=16) mice were used in this experiment. All
animals were male, aged 12-16 weeks and weighed 20-25 grams. Sham operated animals (n=16) for each
group were also studied. In each group 8 hearts were collected for protein analysis while the other 8 hearts
were collected for histological analysis.
All experimental animal procedures were approved by the Animals Ethics Committee of the College of
Medicine and Health Sciences, UAE University.
Wild type and GAL-3 KO mice were anesthetized by an intraperitoneal injection of a combination of
Ketamine (100mg/kg) and Xylazine (10mg/kg). The mice were then intubated and connected to a mouse
ventilator (Harvard apparatus Minivent Hugo Sachs Electronik) which supplied room air supplemented
with 100 % oxygen (tidal volume 0.2 ml/min., rate 120 strokes/min). Body temperature was continuously
monitored and maintained within 36-37°C. The lead II ECG (ADInstrument multi-channel recorder interfaced
with a computer running Power lab 4/30 data acquisition software) was recorded from needle electrodes
inserted subcutaneously. Myocardial infarction was induced in the mice by permanently occluding the left
anterior descending coronary artery (LAD) as described earlier [31-33].
Briefly, the chest was opened with a lateral incision at the 4th intercostal space on the left side of the
sternum. Next the chest wall was retracted for better visualization of the heart. With minimal manipulation,
the pericardial sac removed and the left anterior descending artery (LAD) visualized with a stereomicroscope
(Zeiss STEMI SV8). An 8-0 silk suture was passed under the LAD, a small 1 mm polyethylene tubing (PE)
was placed on top of the LAD and the suture was ligated on the top of the PE tubing without damaging the
artery. Ischemia was confirmed by the pale discoloration of the left ventricle. An accompanying ECG also
showed corresponding ST- elevation. After 30 minutes of ischemia the ligature is removed by cutting the
knot on top of this PE tube. Reperfusion was confirmed visually and by ECG changes.
The chest wall was closed by approximating the third and fourth ribs with one or two interrupted
sutures. The muscles returned back to their original position and the skin closed with 4-0 prolene suture.
The animal was gently disconnected from the ventilator and spontaneous breathing was seen immediately.
Postoperative analgesic (Butorphanol 2mg/kg, s/c, 6 hourly) was given at the end of the procedure. Sham
operated mice underwent exactly the same procedure described above, except that the suture passed under
the LAD is left open and untied. According to the experimental protocol, mice were sacrificed 24 hours after
induction of myocardial ischemia reperfusion. The hearts were washed in ice cold PBS, right ventricle and
both atria dissected away and left ventricle immediately frozen in liquid nitrogen and later stored in -80 °C
freezer. Blood was also collected in EDTA vacutainers and centrifuged at 3000 RPM for 15 minutes. The
plasma was collected, alliquoted and stored at -80 °C until further analysis. Heart samples from the same
time point following LAD ligation were fixed in 10% buffered formal-saline for 24 hours.

Protein extraction from samples
Total protein was extracted from heart samples by homogenizing with lysis buffer and collecting the
supernatant after centrifugation. The Left ventricular (LV) heart samples were thawed, weighed and put in
cold lysis buffer containing 50mM Tris, 300mM NaCl, 1mM MgCl2, 3mM EDTA, 20mM β-glycerophosphate,
25mM NaF, 1% Triton X-100, 10%w/v Glycerol and protease inhibitor tablet (Roche Complete protease
inhibitor cocktail tablets). The hearts were homogenized on ice by a homogenizer (IKA T25 Ultra Turrax).
The samples were then centrifuged at 14000 RPM for 15 minutes at 4 °C, supernatant collected, alliquoted
and stored at -80°C until further analysis. Total protein concentration was determined by BCA protein assay
method (Thermo Scientific Pierce BCA Protein Assay Kit).
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Immunohistochemistry
Hearts were excised, washed with ice-cold (PBS), blotted with filter paper and weighed. Each heart
was sectioned into coronal slices of 2mm thickness then cassetted and fixed directly in 10% neutral
formalin for 24 hours, which was followed by dehydration in increasing concentrations of ethanol, clearing
with xylene and embedding with paraffin. Five-micrometer sections were prepared and mounted on
aminopropyltriethoxysilane (APES) coated slides. After dewaxing with xylene and rehydrating with graded
alcohol, slides were placed in a 0.01 M citrate buffer solution (pH=6.0) and pre-treatment procedures to
unmask the antigens was performed in a water bath at 95°C for 30 minutes. Then, sections were treated with
peroxidase block for 60 minutes followed by protein block for 60 minutes. Sections were incubated overnight
with anti- GAL-3 antibody (rabbit anti-mouse polyclonal antibody 1:2500, Davids Biotechnologie GmbH,
Germany) and anti-Catalase antibody (Rabbit Polyclonal, 1:400, Sigma, USA) at 4°C. While other sections
were incubated with anti- cleaved caspase-3 antibody (Rabbit Polyclonal, 1:300, Cell signaling technology,
USA), anti-cytochrome C antibody (Rabbit Polyclonal, 1:300, Cell signaling technology, USA), anti-nuclear
factor erythroid 2–related factor 2(NRF-2) antibody (Rabbit Polyclonal, 1:100, Abcam, USA), anti-glutathione
peroxidase antibody (Rabbit Polyclonal, 1:300, Abcam, USA), Anti- Superoxide dismutase (SOD) antibody
(Rabbit Polyclonal, 1:300, Abcam, USA), anti-glutathione reductase antibody (Rabbit Polyclonal, 1:300,
Abcam, USA), for one hour at room temperature. After conjugation with primary antibodies, sections were
incubated with secondary antibody (EnVisionTM Detection System, DAKO, Agilent, USA) for 20 minutes at
room temperature followed by addition of DAB chromogen (EnVisionTM Detection System, DAKO, Agilent,
USA) and counter staining done with haematoxylin. Appropriate positive controls were used. For negative
control, the primary antibody was not added to sections. Positive and negative controls were used in every
batch of slides that were stained (not shown in figures).

Immunofluorescent labeling
Five-um sections were deparaffinised with xylene and rehydrated with graded alcohol. Sections were
placed in EnVisionTM FLEX Target Retrieval Solution with a high PH (PH 9) (DAKO Agilent, USA) in a water
bath at 95oC for 30 minutes hour. Sections were washed with distilled water for 5 minutes followed by PBS
for 5 minutes. Later they were incubated with anti-catalase (Rabbit Polyclonal, 1:100, Sigma, USA) antibody,
anti-annexin-V antibody (Rabbit Polyclonal, 1:100, Abcam, USA), anti-myeloperoxidase (MPO) antibody
(Rabbit Polyclonal, 1:100, Abcam, USA), overnight at room temperature. Sections were subsequently
incubated with donkey anti-rabbit Alexa Fluor 488, (Invitrogen, USA, 1:100) antibody. Finally, sections were
mounted in water-soluble mounting media and viewed with Olympus Fluorescent microscope. Appropriate
positive control sections were used. For negative control, the primary antibody was not added to sections
and the whole procedure carried out in the same manner as mentioned above.
Morphometric analysis
Morphometric analysis of NRF2, SOD, glutathione reductase, glutathione peroxidase, catalase,
cytochrome c, cleaved caspase-3 and annexin V expression in left ventricular cells was done at 24h
following ischemia reperfusion using ImageJ software (http://rsbweb.nih.gov/ij/). NRF2, SOD, glutathione
reductase, glutathione peroxidase, catalase, cytochrome c, cleaved caspase-3 and annexin v labeling were
determined by counting the number of positive cells in randomly-selected high power fields (HPF) in the
left ventricle. The mean numbers of positive cells will be converted from per HPF to per mm2 (Each mm2
= 4HPF). For NRF2 labeling, cells were considered positive when there was a nuclear staining pattern. For
SOD, glutathione reductase, glutathione peroxidase, catalase, cytochrome c, cleaved caspase-3 labeling, cells
were considered positive when there was a cytoplasmic staining pattern. For annexin V labeling, cells were
considered positive when there was a membranous/cytoplasmic staining patterns.

Western blotting
Total protein extracts (50 ug) from each sample were resolved by SDSPAGE on 12.5% and 15%
polyacrylamide gels depending on the molecular weight of the protein. The protein on gels was
electrotransferred onto a Polyvinylidene difluoride (PVDF) membrane using Bio-Rad tank transfer system.
The membranes were blocked in 5% non-fat dry milk solution in TBST for one hour at room temperature.
The membranes were subsequently incubated overnight with primary antibodies anti- cleaved caspase-3
(Rabbit Polyclonal, 1:1000, Cell signaling technology, USA), anti-cytochrome C (Rabbit Polyclonal, 1:1000,
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Cell signaling technology, USA), anti BAX (Rabbit Polyclonal, 1:1000, Abcam, USA), anti-BCL2 (Rabbit
Polyclonal, 1:1000, Abcam, USA), diluted in blocking buffer with gentle shaking at 4°C overnight. Membranes
were also incubated overnight 4°C for Beta-actin antibody Rabbit Polyclonal, 1:1000, Cell signaling
technology, USA), diluted in TBST to control for equal loading. Blots were then incubated with horseradish
peroxidase-conjugated secondary antibodies (rabbit anti-mouse Thermo-Pierce) and developed using ECL
plus substrate (Thermo Pierce). Protein bands were visualized by a laser scanner (Typhoon FLA 9500, GE
Healthcare Bio-Sciences AB, Sweden). Densitometric analysis of the protein bands was analyzed using image
J software (https://imagej.nih.gov/ij/), NIH, USA. The blot intensities were normalized with that of β-actin
as loading control.

Enzyme linked immunosorbent assay
Left ventricular myocardial concentration of GAL-3, c-reactive protein (CRP), neutrophil elastase,
myeloperoxidase (MPO), interleukin-6 (IL-6), and cleaved caspase-3 were determined using DuoSet enzyme
linked immunosorbent assay (ELISA) development kits [mouse galectin-3 (DY1197), mouse CRP (DY1829),
mouse neutrophil elastase (DY4517), mouse MPO (DY 3667), mouse IL-6 (DY 406) and mouse cleaved
caspase-3 (DYC 835), R&D Systems, Minneapolis, MN, USA] for sandwich ELISA, using standard procedure
according to the manufacturer’s instructions. The levels were normalized to total protein concentrations.
Briefly, 96-well plates Nunc-Immuno Plate MaxiSorp Surface (NUNC Brand Products, A/S, Roskilde,
Denmark), were coated with antibody specific our proteins of interest. Biotinylated detection antibody and
streptavidin conjugated horseradish peroxidase were used for detection of captured antigens. The plates
between steps were aspirated and washed 3 times using ELISA plate washer (BioTek ELx50). Captured
proteins were visualized using tetramethylbenzidine (TMB)/hydrogen peroxide. Absorbance readings were
made at 450 nm, using a 96-well plate spectrophotometer (BioTek ELx800). Concentrations in the samples
were determined by interpolation from a standard curve. Standards and samples were assayed in duplicate.
Glutathione and Catalase activity assay
Total glutathione level in the heart protein extract was measured by a glutathione (GSH) Assay kit
(CS0260 Sigma-Aldrich). Glutathione standard solutions were used to generate a standard curve and GSH
levels calculated using Megallan6 software. Catalase activity was measured using Cayman Catalase assay kit
(707002, Cayman USA).
Troponin-I Assay
Mouse cardiac troponin I levels in plasma were measured by using a high sensitivity mouse cardiac
Troponin-I Elisa kit (2010-1-HSP, Life Diagnostics, Inc.) according to the manufacturer’s instructions.

Statistical analysis
All statistical analyses were done using GraphPad Prism Software version 5. Comparisons between
the various groups were achieved by one-way analysis of variance (ANOVA), followed by Newman-Keuls
multiple range tests. Data are presented in mean ± standard error (S.E). P values < 0.05 are considered
significant.

Results

GAL-3 is increased after Ischemia-reperfusion injury in the heart
GAL-3 levels were significantly higher in the LV of GAL-3 wild type mice at 30 min
ischemia and 24-hour post reperfusion time point as compared to sham operated mice
(7862 ± 768.8 vs 4785 ± 273.5 pg/mg, P<0.001) as measured by ELISA (Fig. 1A). Our
immunohistochemistry results also show significantly increased expression of GAL-3 in the
heart section of IR group (Fig. 1B, D) as compared to sham-operated animals (Fig. 1C, E).
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Fig. 1. A. The graph
represents
left
ventricular
GAL-3
concentrations in the
wild type C57BL6
IR group and GAL3 KO IR group with
their corresponding
shams. Data are
shown as means
± SEM. Statistical
significance
is
expressed
P<0.05.
B&C
represents
low power view of Figure 1
heart sections showing GAL-3 expression in IR group (B) as compared to Sham operated control group
(C). Expression is seen as more intense staining in the LV area supplied by LAD (arrow heads) as well as
right ventricular wall (thin arrow) (B). D&E show high power view of IR (D) and sham heart sections (E)
expressing GAL-3 in the cytoplasm of cardiomyocytes (arrow head) and nuclei (thin arrow), endothelial
cells (thick arrow) and neutrophil polymorphs (curved arrow) (D). The intensity and number of positive
staining in IR group is higher than the Sham. Streptavidin- biotin immunoperoxidase method.
Fig. 2. A. The graph
represents left ventricular
IL6 concentrations in the
wild type C57BL6 IR group
and GAL-3 KO IR group
with their corresponding
shams. B. The graph
represents left ventricular
CRP concentrations in the
wild type C57BL6 IR group
and GAL-3 KO IR group
with their corresponding
shams. C. The graph
represents left ventricular
MPO concentrations in the
wild type C57BL6 IR group
and GAL-3 KO IR group
with their corresponding
shams. D. The graph
represents left ventricular
elastase
concentrations
in the wild type C57BL6
IR group and GAL-3
KO IR group with their
corresponding shams. Data are shown as means ± SEM. Statistical significance is expressed p<0.05.

Figure 2
GAL-3 is associated with
increased inflammatory response following Ischemia-reperfusion
injury in the heart
IL-6 levels in the LV of the IR GAL-3 wild group were significantly raised as compared to
the IR GAL-3-KO group (61.22 ± 7.144 vs 44.45 ± 2.034 pg/ml, P<0.05) (Fig. 2A). CRP levels
in the LV of the IR GAL-3 wild group were significantly raised as compared to the IR GAL3-KO group (86010 ± 7918 vs 21470 ± 545.3.6 pg/ml, P<0.001) (Fig. 2B). Neutrophil MPO
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levels in the LV of the IR GAL-3 wild group were significantly raised as compared to IR GAL-3KO group (358700 ± 20320 vs 293900 ± 19070pg/ml, P<0.01) (Fig. 2C). Neutrophil elastase
levels in the LV of the IR GAL-3 wild group were significantly raised as compared to the IR
GAL-3-KO group (16740 ± 1802 vs 9735 ± 1643 pg/ml, P<0.01)(Fig. 2D). Immunofluorescent
staining of the heart section with MPO showed a comparatively higher number of neutrophil
polymorphs in the IR GAL-3 wild group than IR GAL-3-KO group (Fig. 3).

GAL-3 has an anti-oxidant effect in IR injury
To assess the effect of GAL-3 on the oxidative stress we measured the status of the
antioxidant enzymes total glutathione and catalase in the LV tissue protein extract in
the GAL-3 wild type IR group and GAL-3 KO IR group. Total glutathione levels were
significantly raised in the GAL-3 wild type IR group (Fig. 4A) compared to the GAL-3 KO IR
group (5.083 ± 0.6114 vs 2.707 ± 0.296 nmol/ mg protein, P<0.001). Total catalase levels
were significantly raised in the GAL-3 wild type IR group (Fig. 4B) compared to the GAL3 KO IR group (183.3 ± 4.032vs 19.90 ± 1.131 nmol/min/ml, P<0.0001). Morphometric
analysis of immunohistochemically stained sections of the LV show a significantly higher
number of cells showing nuclear expression of NRF2 in GAL-3 wild IR group than in GAL3 KO group (90.63 ± 9.517 vs 59.38 ± 8.898, P< 0.05) (Fig. 5 A-C). Morphometric analysis
of immunohistochemically stained sections of the LV show a significantly higher number
of cells showing cytoplasmic expression of SOD (61.63 ± 3.973 vs 50.13 ± 2.936, P< 0.05,
Fig. 5D-F), and Glutathione reductase (43.00 ± 2.872 vs 32.50 ± 3.391, P< 0.01, Fig. 5G-I)
Fig. 3. A&B. Representative
sections of the left ventricle of
IR group showing neutrophil
polymorphs
expressing
MPO
and infiltrating the myocardium
(thin arrow). C&D. Representative
sections of the left ventricle
of IR-KO group showing a
comparatively lower number
of neutrophil polymorphs with
similar expression of MPO, when
compared to the IR group, and
infiltrating the myocardium (thin
arrow), (Alexa Fluor 488).

Figure 3

Fig. 4. The graphs represent
(A) left ventricular total GSH
concentrations in the wild
type C57BL6 IR group and
GAL-3 KO IR group. (B) Left
ventricular catalase activity
in the wild type C57BL6 IR
group and GAL-3 KO IR group.
Data are shown as means ±
SEM. Statistical significance is
expressed p<0.05.
Figure 4
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Fig.
5. Representative
section of left ventricle (LV) showing nuclear expression of NRF2 by cardiac myocytes
Figure
5
(thin arrow) and endothelial cells (arrow head) in IR GAL-3 wild mice (A) and IR GAL-3 KO mice (B). C. The
graph represents morphometric analysis of NRF2 positive cells in GAL-3 wild IR & GAL-3 KO IR groups as
compared to their sham controls. Representative section of LV showing cytoplasmic expression of SOD by
cardiac myocytes (thin arrow) in IR GAL-3 wild mice (D) and IR GAL-3 KO mice (E). F. The graph represents
morphometric analysis of SOD positive cells in GAL-3 wild IR & GAL-3 KO IR groups as compared to their
sham controls. Representative section of LV showing cytoplasmic expression of glutathione reductase
by neutrophil polymorphs (thin arrow) and endothelial cells (arrow head) in IR GAL-3 wild mice (G) and
IR GAL-3 KO mice (H). I, The graph represents morphometric analysis of glutathione reductase positive
cells in GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham controls. Representative section
of LV showing cytoplasmic expression of glutathione peroxidase by neutrophil polymorphs (thin arrow),
endothelial cells (arrow head) and cardiac myocytes (thick arrow) in IR GAL-3 wild mice (J) and IR GAL3 KO mice (K). L. The graph represents morphometric analysis of glutathione peroxidase positive cells in
GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham controls. Data are shown as means ± SEM.
Statistical significance is expressed P<0.05.
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Fig. 6. A&B represent a low power
view of heart sections showing a
significantly increased expression
of catalase (thin arrows) in the
area supplied by the LAD in
GAL-3 wild type IR group (A)
as compared to the GAL-3 KO
IR (B) group, Alexa Fluor 488
immunofluorescent
labeling.
C&D represent high power
view of heart section showing
cardiomyocytes (thin arrows) and
inflammatory cells (arrow heads)
expressing catalase in GAL-3 wild
type IR group (C). GAL-3KO IR
group (D) shows comparatively
fewer cardiomyocytes expressing
catalase and mainly expressed
by inflammatory cells (arrow
heads),
Alexa
Fluor
488
immunofluorescent
labeling.
E, shows a high power view
of GAL-3 wild type IR group
showing catalase expression by
cardiomyocytes (arrow heads),
inflammatory cells (thin arrows).
Some neutrophil polymorphs
are
surrounding
a
dead
cardiomyocyte (thick arrow).
F, represents a corresponding
high power view of heart section
from the GAL-3 KO IR group
with visibly lower catalase
expression in cardiomyocytes
(thick arrow) and mainly
expressed by inflammatory cells
(arrow heads). Alexa Fluor 488
immunofluorescent labeling. G&I
show the low and high power view
of the heart section of the GAL3 wild type IR group expressing
catalase as a cytoplasmic staining
of cardiomyocytes (arrow head)
and endothelial cells (thick
arrow).
Streptavidinbiotin
immunoperoxidase method. H&K Figure 6
represent low and high power views of the GAL-3 KO IR group showing a comparatively lower expression
of catalase by cardiomyocytes (arrow head). Streptavidin- biotin immunoperoxidase method. J. The graph
represents morphometric analysis of catalase positive cells in GAL-3 wild IR & GAL-3 KO IR groups as
compared to their Sham controls. Data are shown as means ± SEM. Statistical significance is expressed
p<0.05.

1131

Physiol Biochem 2018;50:1123-1139
Cellular Physiology Cell
© 2018 The Author(s). Published by S. Karger AG, Basel
DOI: 10.1159/000494539
and Biochemistry Published online: 24 October 2018 www.karger.com/cpb
Al-Salam et al.: Role of Galectin-3 in Myocardial Ischemia Reperfusion Injury

in GAL-3 wild IR group than in GAL-3 KO group, while there was no significant difference in
the expression of glutathione peroxidase between GAL-3 wild IR group and GAL-3 KO group
(40.38 ± 3.433 vs 37.63 ± 2.605, p= 0.5336, Fig. 5J-L).
Morphometric analysis of immunohistochemically stained sections of LV show a higher
number of cells showing cytoplasmic expression of catalase in GAL-3 wild IR group than in
GAL-3 KO group (74.38 ± 2.507 vs 43.50 ± 4.516, P< 0.001, Fig. 6J).

GAL-3 has an antiapoptotic effect in IR injury
Heart LV cleaved caspase-3 levels were significantly increased in the IR KO group as
compared to the IR group (2367 ± 125.0 N=8 vs 2027 ± 93.47 pg/mg protein. P<0.05) using
ELISA technique.
The relative heart LV cleaved caspase-3, cytochrome C, and BAX proteins expressions
normalized to beta actin by western blot technique were significantly increased in IR KO
group as compared to the IR group (0.4758 ± 0.01614 vs 0.1938 ± 0.01097 P<001), (0.6079
± 0.02013 vs 0.3152 ± 0.02035 P <001), and (1.137 ± 0.04690 vs 0.8375 ± 0.02711 P <001)
respectively, (Fig. 7). While the relative heart LV BCL2 protein expression normalized to beta
actin by western blot technique was significantly higher in IR group as compared to the IR
KO group (2.523 ± 0.04012 vs 1.067 ± 0.04912 P<0.001), (Fig. 7).
Fig. 7. A, Western blot
analysis of cleaved
caspase-3, cytochrome
C, BAX, BCL2 and
beta actin proteins in
GAL-3 wild IR & GAL3 KO IR groups as
compared to their sham
controls. B, Graphical
representation
of
densitometry
analysis of cleaved
caspase-3 protein band
normalized to beta actin
band in GAL-3 wild IR &
GAL-3 KO IR groups as
compared to their sham
controls. C. Graphical
representation
of
densitometry analysis
of cytochrome C protein
band normalized to
beta actin band in
GAL-3 wild IR & GAL3 KO IR groups as
compared to their sham
controls. D. Graphical
representation
of
densitometry analysis
of BAX protein band
normalized to beta
Figure 7
actin band in GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham controls. E. Graphical
representation of densitometry analysis of BCL2 protein band normalized to beta actin band in GAL-3 wild
IR & GAL-3 KO IR groups as compared to their sham controls. Data are shown as means ± SEM. Statistical
significance is expressed P<0.05.
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Fig.
8. Representative
section from the left ventricle (LV) showing cytoplasmic expression of cytochrome C
Figure
8
in cardiac myocytes (thin arrow) in IR group (A) and IR-KO group (B). C, The graph represents morphometric
analysis of cytochrome C positive cells in GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham
controls. Data are shown as means ± SEM. Statistical significance is expressed P<0.05. Representative
section from the LV of the showing apoptotic cell expressing cleaved caspase -3 (thin arrow) in IR group
(D) and IR-KO group (E). F. The graph represents morphometric analysis of cleaved caspase-3 positive cells
in GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham controls. Data are shown as means ±
SEM. Statistical significance is expressed P<0.05. Representative section from the LV showing apoptotic cell
expressing Annexin v on the cell membrane (thin arrow) in IR group (G) and IR-KO group (H) (Alexa Fluor
488). I, the graph represents morphometric analysis of annexin V positive cells in GAL-3 wild IR & GAL-3
KO IR groups as compared to their sham controls. Data are shown as means ± SEM. Statistical significance
is expressed P<0.05.

Morphometric analysis of immunohistochemically stained sections of the LV show a
significantly higher number of cells showing cytoplasmic expression of cytochrome C in
GAL-3 KO IR group than in GAL-3 IR wild group (76.50 ± 7.459 vs 53.75 ± 4.317, P< 0.01, Fig.
8A-C) Morphometric analysis of immunohistochemically stained sections of the LV show a
significantly higher number of apoptotic cells stained with cleaved caspase-3 in GAL-3 KO IR
group than in GAL-3 wild IR group (14.00 ± 2.268 vs 7.625 ± 1.558 vs, P< 0.01, Fig. 8D-F).
Morphometric analysis of immunohistochemically stained sections of the LV show a
significantly higher number of apoptotic cells stained with annexin V in GAL-3 KO IR group
than in GAL-3 wild IR group (18.63 ± 2.897 vs 11.13 ± 1.807, P< 0.01, Fig. 8G-I)
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Total Troponin I in IR injury
Plasma Troponin I levels were significantly
increased in the IR KO group as compared to the IR
group (8.96931± 1.3845vs 3.727 ± 1.168 pg/mg protein
P<0.001) (Fig. 9).
Discussion

Myocardial infarction is the leading cause of
death in cardiovascular diseases worldwide. The
magnitude of myocardial injury relates directly to the
degree of reduction of blood flow and to the duration Fig. 9. The graphs represent plasma
of the ischemic insult, which affects the levels to which troponin I concentrations in the wild
cellular ATP and intracellular pH are reduced. The type C57BL6 IR group and GAL-3 KO
impairment of ATPase-dependent ion transport during IR group. Data are shown as means
ischemic insult causes intracellular and mitochondrial ± SEM. Statistical significance is
calcium levels to increase. At the same time cell volume expressed p<0.05.
regulatory mechanisms are disturbed due to the lack of
ATP, which can induce disintegration of micro organelles
and plasma membranes [8, 34]. Reperfusion, although required to rescue ischemic tissues,
produces contradictory tissue responses that stimulate the production of reactive oxygen
species, cause sequestration of proinflammatory cells in ischemic tissues, endoplasmic
reticulum stress, and development of post ischemic capillary no-reflow, which amplifies
tissue injury. These pathologic events terminate in opening of mitochondrial permeability
transition pores as an end result of IR-induced cell death [1, 5, 35].
Blumgart et al. [36] reported that extensive infarction occurred when coronary occlusion
was maintained for 40 minutes or longer, while occlusions of 5–20 minutes did not result in
infarction. With occlusions of intermediate duration, the extent of necrosis depended on the
time to reperfusion [37]. In our project we induced myocardial ischemia for 30 minutes
followed by 24 hours reperfusion creating an environment where ischemic damage is
limited to a time when irreversible damage starts to occur and 24 hour of reperfusion time
gives adequate time for reperfusion related changes to take place.
Our aim in this study is to look at an acute time point after IR to see if GAL-3 plays any
significant protective role at this early stage.
Our results show a significant increase in GAL-3 levels in the heart LV after IR injury as
compared to sham-operated mice signifying that GAL-3 has some roles at this acute stage
after IR. Troponin I, a marker of cardiomyocytes injury, is also significantly higher in GAL-3KO group than GAL-3 wild group. In addition, proapoptotic proteins such as cleaved caspase
3, cytochrome c and annexin V are significantly higher in GAL-3-KO group than GAL-3 wild
group, while BCL2, an antiapoptotic protein, is significantly higher in GAL-3 wild group than
GAL-3-KO group, supporting the notion that the raised GAL-3 post IR injury may in some way
play a protective role (at least at the tested time point) in response to injury. Literature has
many reports regarding anti-apoptotic role of GAL-3. GAL-3 has been shown to translocate
either from the cytosol or from the nucleus to the mitochondria following exposure to
apoptotic stimuli and blocks changes in the mitochondrial membrane potential, thereby
preventing apoptosis [38]. GAL-3 has also been shown to translocate to the perinuclear
membranes and inhibit cytochrome c release from the mitochondria and thereby inhibiting
apoptosis [39]. GAL-3 can inhibit TNF- induced apoptosis through activation of AKT [40].
These anti-apoptotic effects of GAL-3 is further supported by the fact that overexpression of
GAL-3 protects cell damage and death by motivating mitochondrial homeostasis [41].
The antioxidants glutathione and catalase levels are also significantly increased in the
GAL-3 wild group as compared with the GAL-3 KO group. This shows that GAL-3 is associated
with an increase in the antioxidant activity in the IR injured myocardium. The morphometric
Figure 9
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analysis of immunohistochemically-stained sections also shows higher expression of NRF2,
SOD, GSH reductase, and catalase in GAL-3 wild group than in GAL-3 KO group which also
supports antioxidant role of GAL-3. This is another evidence supporting the protective role
of GAL-3 at 24-hour following IR injury.
SOD, glutathione and catalase are the most important cellular defense mechanism
against oxidative injury and are the major intracellular redox buffer in ubiquitous cell types
[42, 43]. Accumulating evidence suggests that the intracellular redox status regulates various
aspects of cellular function [43]. Glutathione and catalase specifically provide significant
antioxidant protection to the myocardium against IR injury [44-47]. Experiments using
isolated heart models in the presence or absence of superoxide dismutase also showed ROS
as likely mediators of reperfusion injury [48, 49].
Studies have shown that GAL-3 actions with regards to oxidative stress are variable;
some point to its role as an inducer of ROS, but other studies explain its role as a molecule
that is protective against ROS mediated injuries. In an ischemia reperfusion model in kidney
it was shown that ROS production was more prominent in GAL-3 wild type mice as compared
to GAL-3 knockout mice [50]. Early data have also demonstrated that GAL-3 could stimulate
superoxide production by neutrophils [51] and by monocytes [52]. So the presence of GAL-3
produces more ROS and more antioxidant proteins.
In our study we found higher anti-oxidant activity in the LV myocardium after IR in
conjunction with less myocardial damage in GAL-3 wild group than GAL-3 KO group. There
can be many explanations for this phenomenon. The function of antioxidant systems is to
modify the highly reactive oxygen species to form intermediates, which no longer pose a
threat to the cell. A balance is essential between oxidation and antioxidant’s level in the
system for healthy biological integrity to be maintained. In previous studies, ischemia and
reperfusion impaired superoxide dismutase activity and decreased cellular glutathione-toglutathione disulfide ratio suggested that the extent of superoxide anion radical produced
at reperfusion exceeded the capacity of endogenous cellular antioxidant systems [53]. But
the same oxidative stress can lead to increase in the antioxidant capacity and so the increase
we see in the antioxidant enzymes may be due to the increase in the oxidative stress. This
phenomenon was observed in a study by Bandeira et al. when the total SOD activity and the
lipid peroxidation were higher in diabetics compared to non-diabetics [54]. Another study
by Savu et al. also showed increase in anti-oxidant capacity despite high levels of oxidative
stress [55]. Cabigas et al. have also shown over expression of catalase in myeloid cells
following acute myocardial infarction [56].
Regarding the role of GAL-3 in IR, Matarrese et al. [41] have reported that GAL-3
interferes with ROS generation and so might interfere with very early stages of cell death that
are associated with perturbation of mitochondrial homeostasis and subsequent formation
of ROS. They also report that overexpression of GAL-3 protects cells from death through
inhibition of ROS formation by promoting mitochondrial homeostasis. Mukaru et al. [57],
have also shown increased GAL-3 is associated with increased GSH level. There is further
evidence in literature that indicate that GAL-3 is protective in IR injuries e.g. GAL-3 was
found to be involved in the kidney regeneration [58] and has also shown to play a protective
role in ischemia reperfusion injury of the liver [59].
Thus the increase in the anti-oxidant activity linked to GAL-3, observed in the present
study, may suggest two possibilities; either it is the result of a possible adaptive response,
probably due to the increased production of the oxidative radicals or due to the inherent role
of GAL-3 in decreasing oxidative stress.
An interesting observation in our study was that the immunohistochemical expression
of NRF2 positive cells was higher in the GAL-3 wild type mice than in GAL-3 KO mice after
IR injury.
This shows that GAL-3 caused an increase in the NRF2 expression in the myocardium.
There have been no reports in literature, to date, showing a direct relationship between GAL3 and NRF2, however, NRF2 has been shown to control intracellular ROS levels following IR
injury in cardiac cell culture [60]. Also in animal experiments, acute activation of NRF2 has
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been shown to be cardioprotective following IR injury [27, 61]. We can therefore hypothesize
that GAL-3 confers protection partly through the NRF2 cytoprotective pathway.
IR injury is also associated with influx of inflammatory cells comprising predominantly
of neutrophil polymorphs. CRP, IL-6, MPO, and neutrophil elastase are reliable markers for
determining the magnitude of inflammatory response [62, 63]. We show significantly higher
levels of LV CRP, IL6, MPO, and neutrophil elastase in IR GAL-3 wild group as compared to
the IR GAL-3 KO group. This observation supports a pro-inflammatory role of GAL-3 in IR
injury. We have identified that knocking out GAL-3 gene results in a significant decrease in
LV inflammatory markers as well as a significant increase in LV cell death. This paradox is
very interesting and suggests multiple roles of GAL-3 in IR injury and that although knocking
out GAL-3 is associated with lowering inflammatory response, it leads to an increase in cell
death through increased apoptotic rate and decreased anti-oxidative activity. All these are
pointing towards a protective role of GAL-3 at 24-hour post IR injury. Although GAL-3‘s role
as a pro-inflammatory mediator is shown in our work and in previous studies [11, 64], we do
not have a clear mechanistic understanding as to how this role reconciles with its protective
role after IR injury.
Conclusion

Our study shows that GAL-3 can affect the redox pathways, controlling cell survival and
death, and play a protective role on the myocardium following IR injury.
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